| Patricia Morehouse Larsen, | |
|
12444 Beach Blvd, Stanton, CA 90680-3930 | |
| (714) 899-1520 | |
| (714) 899-1505 |
| Full Name | Patricia Morehouse Larsen |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 12444 Beach Blvd, Stanton, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790284610 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 41839 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Morehouse Larsen, 5551 Lime Ave, Cypress, CA 90630-3101 Ph: (714) 827-9837 | Patricia Morehouse Larsen, 12444 Beach Blvd, Stanton, CA 90680-3930 Ph: (714) 899-1520 |
News Archive
The Wall Street Journal reports that a recent small study finds that reporting of prescription side effects increases when doctors use computerized patient records. "The study, at Massachusetts General and Brigham & Women's hospitals in Boston and sponsored by Pfizer Inc., showed a large increase in reporting of adverse events to the Food and Drug Administration once doctors used an automated tool.
The Nonalcoholic Steatohepatitis (NASH) Clinical Research Network has launched its second clinical trial to study NASH, a liver disease that resembles alcoholic liver disease but occurs in patients who drink little or no alcohol. The first trial, launched in January of this year, focuses on adults, while the second trial studies the disease in children.
Navidea Biopharmaceuticals, Inc., a specialty pharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its Phase 3 clinical study investigating 99m-Tc-Tilmanocept in oral and squamous cell cancers (SCC) were presented as a poster presentation at the 65th Annual Cancer Symposium of the Society of Surgical Oncology (SSO) meeting held in Orlando, Florida, March 21-24, 2012.
A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL).
"Saving Lives at Birth: A Grand Challenge for Development on Wednesday launched its second call for innovative prevention and treatment approaches for pregnant women and newborns in poor, hard-to-reach communities around the world," a USAID press release states.
› Verified 3 days ago
Dr. Huyentran Ngoc Tran, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7791 Santa Catalina Ave, Stanton, CA 90680 Phone: 714-520-1001 | |
Jessica Dang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12505 Beach Blvd Ste A2, Stanton, CA 90680 Phone: 714-584-9599 | |
Dung Nguyen Do, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12444 Beach Blvd, Stanton, CA 90680 Phone: 714-899-1520 Fax: 714-899-0510 | |
Robert Joseph Pigeon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11900 Beach Blvd, Stanton, CA 90680 Phone: 714-890-9063 | |
Dr. Andrew Hoai Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12505 Beach Blvd Ste A2, Stanton, CA 90680 Phone: 714-584-9599 Fax: 714-248-9115 | |
Anh Mai Vu, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12840 Beach Blvd, Stanton, CA 90680 Phone: 714-230-0126 | |
Christine Dinh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7994 Stepping Stone Cir, Stanton, CA 90680 Phone: 661-435-3755 |